These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29939178)

  • 21. MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation.
    Vroomen LGPH; Scheffer HJ; Melenhorst MCAM; de Jong MC; van den Bergh JE; van Kuijk C; van Delft F; Kazemier G; Meijerink MR
    Eur Radiol; 2017 Jun; 27(6):2521-2531. PubMed ID: 27659702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation.
    Long X; Dai A; Huang T; Niu W; Liu L; Xu H; Yin T; Jiang T; Sun S; Lei P; Li C; Zhu X; Zhao J
    ACS Nano; 2023 Jul; 17(13):12915-12932. PubMed ID: 37352467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery.
    Martin RC; Durham AN; Besselink MG; Iannitti D; Weiss MJ; Wolfgang CL; Huang KW
    J Surg Oncol; 2016 Dec; 114(7):865-871. PubMed ID: 27546233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible electroporation of locally advanced pancreatic cancer.
    Kwon W; Thomas A; Kluger MD
    Semin Oncol; 2021 Feb; 48(1):84-94. PubMed ID: 33648735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.
    van den Bos W; de Bruin DM; Muller BG; Varkarakis IM; Karagiannis AA; Zondervan PJ; Laguna Pes MP; Veelo DP; Savci Heijink CD; Engelbrecht MRW; Wijkstra H; de Reijke TM; de la Rosette JJMCH
    BMJ Open; 2014 Oct; 4(10):e006382. PubMed ID: 25354827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
    Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
    Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer.
    Hong Y; Rice J; Sharma D; Martin RCG
    Am J Surg; 2018 Jul; 216(1):106-110. PubMed ID: 29506753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer.
    He C; Huang X; Zhang Y; Lin X; Li S
    Clin Transl Med; 2020 Jun; 10(2):e39. PubMed ID: 32508058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer.
    Moris D; Machairas N; Tsilimigras DI; Prodromidou A; Ejaz A; Weiss M; Hasemaki N; Felekouras E; Pawlik TM
    Ann Surg Oncol; 2019 Jun; 26(6):1657-1668. PubMed ID: 30843163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan.
    Sugimoto K; Moriyasu F; Tsuchiya T; Nagakawa Y; Hosokawa Y; Saito K; Tsuchida A; Itoi T
    Intern Med; 2018 Nov; 57(22):3225-3231. PubMed ID: 29984761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
    Martin RC; McFarland K; Ellis S; Velanovich V
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
    Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
    J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage III pancreatic cancer and the role of irreversible electroporation.
    Al Efishat M; Wolfgang CL; Weiss MJ
    BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the Regulatory Immunomodulation Effect of Irreversible Electroporation (IRE) in Pancreatic Adenocarcinoma.
    Pandit H; Hong YK; Li Y; Rostas J; Pulliam Z; Li SP; Martin RCG
    Ann Surg Oncol; 2019 Mar; 26(3):800-806. PubMed ID: 30610562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report.
    Scheffer HJ; Melenhorst MC; Vogel JA; van Tilborg AA; Nielsen K; Kazemier G; Meijerink MR
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):760-5. PubMed ID: 25288173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review.
    Charalambous P; Moris D; Karachaliou GS; Papalampros A; Dimitrokallis N; Tsilimigras DI; Oikonomou D; Petrou A
    Eur J Surg Oncol; 2020 Sep; 46(9):1565-1572. PubMed ID: 32536525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors.
    Papamichail M; Ali A; Pizanias M; Peddu P; Karani J; Heaton N
    Korean J Hepatobiliary Pancreat Surg; 2016 Aug; 20(3):116-20. PubMed ID: 27621748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
    Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
    J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.